Cogley Brian has filed 6 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 100000 shares of Coeptis Therapeutics Holdings, Inc. ($COEP) on April 27, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 27, 2026 | Coeptis Therapeutics Holdings, Inc. | $COEP | Cogley Brian | Chief Financial Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 4,745,089 | 9999.99% | 2.11% |
| April 27, 2026 | Coeptis Therapeutics Holdings, Inc. | $COEP | Cogley Brian | Chief Financial Officer | A | Restricted Stock Units | 16447 | $0.00 | 16,447.0000 | 4,745,089 | 9999.99% | 0.35% |
| Feb. 11, 2026 | Coeptis Therapeutics Holdings, Inc. | $COEP | Cogley Brian | Chief Financial Officer | M | Common stock | 10000 | $10.56 | 22,500.0000 | 4,745,089 | 80.00% | 0.21% |
| Feb. 11, 2026 | Coeptis Therapeutics Holdings, Inc. | $COEP | Cogley Brian | Chief Financial Officer | A | Common Stock | 12500 | $0.00 | 22,500.0000 | 4,745,089 | 125.00% | 0.26% |
| March 4, 2025 | Coeptis Therapeutics Holdings, Inc. | $COEP | Cogley Brian | Chief Financial Officer | A | Non-Qualified Stock Options (right to buy) | 10000 | $0.00 | 22,500.0000 | 1,924,639 | 80.00% | 0.52% |
| Jan. 10, 2024 | Coeptis Therapeutics Holdings, Inc. | $COEP | Cogley Brian | Chief Financial Officer | P | Common Stock | 5000 | $0.67 | 30,000.0000 | 1,284,499 | 20.00% | 0.39% |